HIV-infection/Aids Clinical Trial
Official title:
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
This study will implement a peer navigation intervention to improve linkage to and retention in HIV care for inmates released from L.A. county jail into the community.
The proposed study has two Primary Specific Aims: 1. To examine individual-level and structural-level barriers to HIV care after release from jail, using formative semi-structured interviews with ex-inmates, case managers, and HIV care providers; and to use the information we obtain to inform the adaptation and tailoring of an intervention designed to improve linkage with and retention to HIV care for HIV+ ex-inmates (Complete); 2. Using a two-group experimental RCT design, to test the adapted peer navigation intervention condition for HIV+ inmates upon release from jail compared to a usual care condition, and to evaluate the intervention's effectiveness at improving linkage with and retention in HIV care, self-reported ART adherence, and HIV RNA viral load suppression; The intervention is hypothesized to result in greater linkage to care, a greater proportion completing at least three HIV care visits per year, increased self-reported ART adherence, and decreased levels of HIV RNA viral load compared to the usual care control group. Secondary Aims of the study include assessing the potential moderating effects of substance abuse, the potential mediating effects of substance abuse treatment, and the program's effects on recidivism, and costs. Active substance abuse is hypothesized to moderate the effect of the intervention, such that the intervention will be less effective among participants who report substance use. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00787696 -
Healthy Teen Girls: HIV Risk Reduction
|
Phase 1/Phase 2 | |
Completed |
NCT03403569 -
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
|
Phase 3 | |
Completed |
NCT02433743 -
Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA
|
N/A | |
Recruiting |
NCT02753049 -
Adherence Connection for Counseling, Education, and Support
|
N/A | |
Completed |
NCT01360762 -
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
|
Phase 3 | |
Recruiting |
NCT03147859 -
Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection
|
Phase 2 | |
Recruiting |
NCT04297488 -
Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection
|
N/A | |
Completed |
NCT01827540 -
Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
|
Phase 1 | |
Completed |
NCT01475890 -
Vitamin D Supplementation in HIV
|
Phase 2/Phase 3 | |
Recruiting |
NCT05947539 -
Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention
|
N/A | |
Withdrawn |
NCT01442428 -
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
|
Phase 2/Phase 3 | |
Completed |
NCT02496793 -
Community-Based Peer Facilitator Intervention (Zimbabwe)
|
N/A | |
Completed |
NCT03069235 -
Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program
|
N/A | |
Completed |
NCT03794648 -
The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication
|
N/A | |
Withdrawn |
NCT04183738 -
Inflammation and Co-Infections in D²EFT
|
Phase 4 | |
Enrolling by invitation |
NCT03919695 -
Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda
|
N/A | |
Recruiting |
NCT04215926 -
NAFLD in HIV-infected Patients
|
||
Completed |
NCT04371835 -
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
|
||
Completed |
NCT01140633 -
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
|
N/A | |
Enrolling by invitation |
NCT04373551 -
WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)
|
N/A |